Topic: drug delivery

  • Aerska's $39M Boost Targets Brain-Delivery for RNA Medicines

    Aerska's $39M Boost Targets Brain-Delivery for RNA Medicines

    Aerska, a Dublin biotech firm, has secured $39 million to develop a delivery system that can transport advanced genetic medicines across the protective blood-brain barrier to treat neurodegenerative diseases. The company's technology aims to use RNA interference to target and reduce the productio...

    Read More »
  • Nephrogen's AI Gene Therapy Aims to Reverse Kidney Disease

    Nephrogen's AI Gene Therapy Aims to Reverse Kidney Disease

    Demetri Maxim was inspired by his family's experience with Polycystic Kidney Disease (PKD), which he also inherited, leading him to pursue a cure for genetic kidney disorders. In 2022, he founded Nephrogen, a biotech startup that uses AI and advanced screening to develop an efficient delivery sys...

    Read More »